Cambridge Cognition Holdings plc (COG) Ordinary 1p
![](https://online.hl.co.uk/img/hl/layout/security-nochange-arrow.gif)
- Add to watchlist
- Create an alert
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-nochange-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-nochange-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
Share news, reports & tips
-
Cambridge Cognition forms scientific advisory board
21 March 2024 16:26
(Sharecast News) - Digital brain health solutions developer Cambridge Cognition announced the creation of a scientific advisory board on Thursday.
-
Cambridge Cognition inks strategic partnership with ActiGraph
21 February 2024 12:17
(Sharecast News) - Brain health specialist Cambridge Cognition announced a strategic partnership with ActiGraph, a provider of wearable technologies tailored for clinical trials, on Wednesday.
-
Cambridge Cognition secures 'significant contract'
11 October 2023 10:04
(Sharecast News) - Digital solutions group Cambridge Cognition has secured a "significant contract" for a "sizeable" later-stage clinical trial, following a competitive tender.
-
Cambridge Cognition wins £2m cancer therapy trial contract
13 June 2023 14:45
(Sharecast News) - Brain health assessment specialist Cambridge Cognition has secured a £2m contract for a significant cancer therapy trial, it announced on Tuesday.
-
Cambridge Cognition wins two contracts worth £2.1m
12 April 2023 14:32
(Sharecast News) - Brain health technology specialist Cambridge Cognition has won two contracts worth more than £2.1m, it announced on Wednesday.
-
Director dealings: Cambridge Cognition CEO makes share purchase
6 February 2023 15:11
(Sharecast News) - Cambridge Cognition revealed on Monday that chief executive Matthew Stork had acquired 13,500 ordinary shares in the AIM-listed technology company.
-
Cambridge Cognition finds local partner for China expansion
24 November 2022 13:30
(Sharecast News) - Brain health technology developer Cambridge Cognition announced an expansion in the Chinese market through a strategic partnership with Luca Healthcare on Thursday.
-
Cambridge Cognition agrees £1.7m purchase of eClinicalHealth
12 October 2022 13:01
(Sharecast News) - Brain health specialise Cambridge Cognition has agreed to acquire virtual clinical trial solution provider eClinicalHealth (eCH), it announced on Wednesday, for up to £1.7m.
-
Director dealings: Cambridge Cognition execs invest after solid update
22 July 2022 14:04
(Sharecast News) - Cambridge Cognition was among a relatively thin list of director deals on Friday afternoon, after two of its executives made share purchases.
-
Cambridge Cognition wins phase 3 contract worth over £1m
28 March 2022 12:41
(Sharecast News) - Brain health technology developer Cambridge Cognition has won a contract worth just over £1m with an unnamed "top 10" pharmaceutical company, it announced on Monday, to provide...
-
Sunday share tips: Cambridge Cognition Holdings, FRP
27 March 2022 10:38
(Sharecast News) - The Sunday Times's Lucy Tobin tipped shares of neuroscience outfit Cambridge Cognition Holdings to readers.
-
Cambridge Cognition awarded contracts worth £2.1m
2 February 2022 12:40
(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts worth £2.1m, it announced on Wednesday, to provide cognitive assessments, electronic diaries, and...
Company announcements Announcements
-
Holding(s) in Company
12 August 2024 12:15
Cambridge Cognition Holdings
-
Issue of Equity and Total Voting Rights
26 July 2024 07:00
Cambridge Cognition Holdings
-
Trading Update & Board Change
23 July 2024 07:00
Cambridge Cognition Holdings
-
Cambridge Cognition secures Innovate UK grant
11 July 2024 07:00
Cambridge Cognition Holdings
-
Holding(s) in Company
1 July 2024 16:20
Cambridge Cognition Holdings
-
Grant of Options
1 July 2024 07:00
Cambridge Cognition Holdings
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.